OraSure Technologies | OSUR - Operating Expenses

Stock Price
3.14
Daily Change
0.08 2.61%
Monthly
1.95%
Yearly
-7.37%
Q1 Forecast
2.86

OraSure Technologies reported $40.35M in Operating Expenses for its fiscal quarter ending in December of 2025.





Operating Expenses Change Date
Agilent USD 1.44B 27M Dec/2025
AngioDynamics USD 81.95M 1.68M Sep/2025
Becton, Dickinson and Co. USD 4.59B 476M Dec/2025
Bio Techne USD 241.42M 2.52M Dec/2025
Bio-Rad Laboratories USD 6.74B 6.16B Sep/2025
Bruker USD 900.9M 124.3M Dec/2025
Cerus USD 34.78M 2.98M Dec/2024
Charles River Laboratories USD 918.41M 2.49B Dec/2025
Danaher USD 5.34B 45.74B Dec/2025
Dentsply International USD 423M 1.06B Dec/2025
Dexcom USD 936.6M 30.2M Dec/2025
Hologic USD 349.4M 447.1M Dec/2025
Illumina USD 903M 69M Dec/2025
Integra LifeSciences USD 368.92M 668.65M Dec/2025
Intuitive Surgical USD 2B 263.6M Dec/2025
IQVIA Holdings USD 1.69B 4.47B Dec/2025
Mesa Laboratories USD 33.98M 2.03M Dec/2024
Mettler Toledo International USD 777.8M 42.3M Dec/2025
Myriad Genetics USD 212.8M 16.2M Dec/2025
OraSure Technologies USD 40.35M 2.45M Dec/2025
Quidel USD 760.9M 1.28B Dec/2025
Repligen USD 177.94M 1.82M Dec/2025
Revvity USD 626.22M 25.62M Dec/2025
STAAR Surgical USD 68.74M 1.55M Dec/2025
Thermo Fisher Scientific USD 9.91B 867M Dec/2025
Trinity Biotech USD 14.82M 7.81M Sep/2025
Waters USD 661.85M 1.67B Dec/2025